Established in 2009, Hubei Soundny Biotechnology is a Chinese biotech enterprise specializing in the research, development, and application of a drug-loaded vesicle treatment for cancer. They focus on various types of solid tumors and complications, such as cholangiocarcinoma, lung cancer, malignant pleural effusion, and malignant ascites. With their patented drug-loaded vesicle treatment, they aim to enhance the effectiveness of chemotherapy and provide better outcomes for cancer patients. The company has already received marketing approval in multiple provinces in China and has successfully conducted clinical trials. Their innovative approach offers a promising solution in the field of oncology treatment.